Updates

The COVID-19 Updates and Situation Report brings together news about the Global Fund partnership’s response to the pandemic. We publish a new issue when there are developments. The situation reports and news are brought together here.

  • 20 January 2022
    COVID-19 Response in Thailand
    According to latest WHO figures, as of 17 January 2022, Thailand has recorded over 2.3 million confirmed cases of COVID-19 with over 21,800 deaths. Thailand was the first country outside of China to report a COVID-19 case.
  • 20 January 2022
    COVID-19 Response in the Philippines
    The Philippines has been severely affected by COVID-19. According to latest WHO figures, as of 17 January 2022, the Philippines had recorded over 3 million confirmed cases of COVID-19 with over 52,700 deaths. Since March 2020, the country has taken s...
  • 21 December 2021
    COVID-19 Response in Ethiopia
    According to latest WHO figures, as of 13 December 2021, Ethiopia has recorded over 372,000 confirmed cases of COVID-19 with over 6,800 deaths. Following the first registered case in March 2020, all health facilities diverted their available resource...
  • 20 December 2021
    COVID-19 Response in Malawi
    According to latest WHO figures, as of 13 December 2021, Malawi has recorded over 62,000 confirmed cases of COVID-19 with over 2,300 deaths since the first case was confirmed in April 2020. While a high proportion of cases have been seen in the urban...
  • 20 December 2021
    COVID-19 Response in Peru
    Since the start of the pandemic in March 2020, COVID-19 has had a devastating impact on Peru's health system and economy, and has disrupted HIV and TB services. Peru is among the countries ranked highest in the world in terms of excess mortality per ...
  • 02 December 2021
    The Global Fund Achieves Significant Price Reductions for Antigen Rapid Diagnostic Tests (Ag RDTS)
    A new agreement reached by the Global Fund and several producers of COVID-19 antigen rapid diagnostic tests (Ag RDTs) has resulted in a significant drop in the price of these tests, potentially making the products more affordable for many governments...